Literature DB >> 24706027

Ketone body metabolism and its defects.

Toshiyuki Fukao1, Grant Mitchell, Jörn Oliver Sass, Tomohiro Hori, Kenji Orii, Yuka Aoyama.   

Abstract

Acetoacetate (AcAc) and 3-hydroxybutyrate (3HB), the two main ketone bodies of humans, are important vectors of energy transport from the liver to extrahepatic tissues, especially during fasting, when glucose supply is low. Blood total ketone body (TKB) levels should be evaluated in the context of clinical history, such as fasting time and ketogenic stresses. Blood TKB should also be evaluated in parallel with blood glucose and free fatty acids (FFA). The FFA/TKB ratio is especially useful for evaluation of ketone body metabolism. Defects in ketogenesis include mitochondrial HMG-CoA synthase (mHS) deficiency and HMG-CoA lyase (HL) deficiency. mHS deficiency should be considered in non-ketotic hypoglycemia if a fatty acid beta-oxidation defect is suspected, but cannot be confirmed. Patients with HL deficiency can develop hypoglycemic crises and neurological symptoms even in adolescents and adults. Succinyl-CoA-3-oxoacid CoA transferase (SCOT) deficiency and beta-ketothiolase (T2) deficiency are two defects in ketolysis. Permanent ketosis is pathognomonic for SCOT deficiency. However, patients with "mild" SCOT mutations may have nonketotic periods. T2-deficient patients with "mild" mutations may have normal blood acylcarnitine profiles even in ketoacidotic crises. T2 deficient patients cannot be detected in a reliable manner by newborn screening using acylcarnitines. We review recent data on clinical presentation, metabolite profiles and the course of these diseases in adults, including in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24706027     DOI: 10.1007/s10545-014-9704-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  80 in total

1.  Mitochondrial acetoacetyl-CoA thiolase (beta-ketothiolase) deficiency and pregnancy.

Authors:  A C Sewell; J Herwig; I Wiegratz; W Lehnert; H Niederhoff; X Q Song; N Kondo; T Fukao
Journal:  J Inherit Metab Dis       Date:  1998-06       Impact factor: 4.982

2.  Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Authors:  David G Cotter; D André d'Avignon; Anna E Wentz; Mary L Weber; Peter A Crawford
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  A series of pregnancies in women with inherited metabolic disease.

Authors:  Janneke G Langendonk; Jonathan C P Roos; Lindsay Angus; Monique Williams; François P J Karstens; Johannes B C de Klerk; Charlé Maritz; Tawfeg Ben-Omran; Catherine Williamson; Robin H Lachmann; Elaine Murphy
Journal:  J Inherit Metab Dis       Date:  2011-09-15       Impact factor: 4.982

4.  Refining the diagnosis of mitochondrial HMG-CoA synthase deficiency.

Authors:  R Aledo; C Mir; R N Dalton; C Turner; J Pié; F G Hegardt; N Casals; M P Champion
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

5.  A common mutation, R208X, identified in Vietnamese patients with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency.

Authors:  Toshiyuki Fukao; Hoan Thi Nguyen; Nhan Thu Nguyen; Dung Chi Vu; Ngoc Thi Bich Can; Anh Thi Van Pham; Khanh Ngoc Nguyen; Hironori Kobayashi; Yuki Hasegawa; Thao Phuong Bui; Kary E Niezen-Koning; Ronald J A Wanders; Tom de Koning; Liem Thanh Nguyen; Seiji Yamaguchi; Naomi Kondo
Journal:  Mol Genet Metab       Date:  2010-01-21       Impact factor: 4.797

6.  Patients homozygous for the T435N mutation of succinyl-CoA:3-ketoacid CoA Transferase (SCOT) do not show permanent ketosis.

Authors:  Toshiyuki Fukao; Haruo Shintaku; Ryou Kusubae; Gai X Zhang; Kozue Nakamura; Masashi Kondo; Naomi Kondo
Journal:  Pediatr Res       Date:  2004-10-20       Impact factor: 3.756

Review 7.  Inborn errors of ketogenesis and ketone body utilization.

Authors:  Jörn Oliver Sass
Journal:  J Inherit Metab Dis       Date:  2011-04-09       Impact factor: 4.982

8.  Succinyl-CoA: 3-ketoacid CoA-transferase deficiency. A cause for ketoacidosis in infancy.

Authors:  J T Tildon; M Cornblath
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

9.  Prenatal diagnosis of succinyl-coenzyme A:3-ketoacid coenzyme A transferase deficiency.

Authors:  T Fukao; X Q Song; H Watanabe; K Hirayama; H Sakazaki; H Shintaku; M Imanaka; T Orii; N Kondo
Journal:  Prenat Diagn       Date:  1996-05       Impact factor: 3.050

10.  D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD).

Authors:  Johan L K Van Hove; Stephanie Grünewald; Jaak Jaeken; Philippe Demaerel; Peter E Declercq; Pierre Bourdoux; Klary Niezen-Koning; John E Deanfeld; James V Leonard
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

View more
  54 in total

Review 1.  Essential roles of four-carbon backbone chemicals in the control of metabolism.

Authors:  Sabrina Chriett; Luciano Pirola
Journal:  World J Biol Chem       Date:  2015-08-26

2.  Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.

Authors:  Hamid Noorbakhsh; Masoud Yavarmanesh; Seyed Ali Mortazavi; Peyman Adibi; Ali A Moazzami
Journal:  Eur J Nutr       Date:  2018-11-03       Impact factor: 5.614

3.  Hepatocyte-specific Sirt6 deficiency impairs ketogenesis.

Authors:  Lei Chen; Qinhui Liu; Qin Tang; Jiangying Kuang; Hong Li; Shiyun Pu; Tong Wu; Xuping Yang; Rui Li; Jinhang Zhang; Zijing Zhang; Ya Huang; Yanping Li; Min Zou; Wei Jiang; Tao Li; Meng Gong; Lu Zhang; Hua Wang; Aijuan Qu; Wen Xie; Jinhan He
Journal:  J Biol Chem       Date:  2018-12-10       Impact factor: 5.157

4.  Clinical and Mutational Characterizations of Ten Indian Patients with Beta-Ketothiolase Deficiency.

Authors:  Elsayed Abdelkreem; Radha Rama Devi Akella; Usha Dave; Sudhir Sane; Hiroki Otsuka; Hideo Sasai; Yuka Aoyama; Mina Nakama; Hidenori Ohnishi; Shaimaa Mahmoud; Mohamed Abd El Aal; Toshiyuki Fukao
Journal:  JIMD Rep       Date:  2016-12-08

5.  Successful Management of Pregnancies in Patients with Inherited Disorders of Ketone Body Metabolism.

Authors:  Raashda Ainuddin Sulaiman; Maha Al-Nemer; Rubina Khan; Munirah Almasned; Bedour S Handoum; Zuhair N Al-Hassnan
Journal:  JIMD Rep       Date:  2017-05-10

6.  Heterozygous carriers of succinyl-CoA:3-oxoacid CoA transferase deficiency can develop severe ketoacidosis.

Authors:  Hideo Sasai; Yuka Aoyama; Hiroki Otsuka; Elsayed Abdelkreem; Yasuhiro Naiki; Mitsuru Kubota; Yuji Sekine; Masatsune Itoh; Mina Nakama; Hidenori Ohnishi; Ryoji Fujiki; Osamu Ohara; Toshiyuki Fukao
Journal:  J Inherit Metab Dis       Date:  2017-07-10       Impact factor: 4.982

7.  Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency: Unique Presenting Laboratory Values and a Review of Biochemical and Clinical Features.

Authors:  Erin Conboy; Filippo Vairo; Matthew Schultz; Katherine Agre; Ross Ridsdale; David Deyle; Devin Oglesbee; Dimitar Gavrilov; Eric W Klee; Brendan Lanpher
Journal:  JIMD Rep       Date:  2017-10-14

8.  A Case of Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency Presenting with Severe Acidosis in a 14-Month-Old Female: Evidence for Pathogenicity of a Point Mutation in the OXCT1 Gene.

Authors:  Daniel J Zheng; Michael Hooper; Michele Spencer-Manzon; Richard W Pierce
Journal:  J Pediatr Intensive Care       Date:  2017-07-19

9.  Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals.

Authors:  Monica H Wojcik; Klaas J Wierenga; Lance H Rodan; Inderneel Sahai; Sacha Ferdinandusse; Casie A Genetti; Meghan C Towne; Roy W A Peake; Philip M James; Alan H Beggs; Catherine A Brownstein; Gerard T Berry; Pankaj B Agrawal
Journal:  JIMD Rep       Date:  2017-07-20

10.  The management of pregnancy and delivery in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency.

Authors:  Angela Pipitone; Donna B Raval; Jessica Duis; Hilary Vernon; Regina Martin; Ada Hamosh; David Valle; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2016-03-21       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.